Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1984 1
1986 1
1987 2
1988 1
1990 1
1991 2
1992 1
1993 1
1995 1
1996 1
1997 2
1998 1
2001 2
2002 3
2003 1
2005 2
2006 1
2007 2
2008 1
2009 2
2010 2
2011 4
2012 1
2013 2
2014 1
2016 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
[Anticoagulation and atrial fibrillation].
Prieto S, Young P, Ceresetto JM, Bullorsky EO. Prieto S, et al. Among authors: bullorsky eo. Medicina (B Aires). 2011;71(3):274-82. Medicina (B Aires). 2011. PMID: 21745781 Review. Spanish.
[Plasma cell leukemias].
Bullorsky EO, Venditti J, Shanley C, Rabinovich O, Lajous JR. Bullorsky EO, et al. Medicina (B Aires). 1987;47(4):399-402. Medicina (B Aires). 1987. PMID: 3452731 Spanish. No abstract available.
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib.
Ottmann O, Saglio G, Apperley JF, Arthur C, Bullorsky E, Charbonnier A, Dipersio JF, Kantarjian H, Khoury HJ, Kim DW, Healey D, Strauss L, Cortes JE. Ottmann O, et al. Among authors: bullorsky e. Blood Cancer J. 2018 Sep 3;8(9):88. doi: 10.1038/s41408-018-0122-3. Blood Cancer J. 2018. PMID: 30190469 Free PMC article. No abstract available.
[Hemophagocytic syndrome. Report of four cases].
Young P, Peroni J, Finn BC, Venditti JE, Preiti V, Bullorsky E, Bruetman JE. Young P, et al. Among authors: bullorsky e. Rev Med Chil. 2011 Feb;139(2):224-9. Epub 2011 Jul 11. Rev Med Chil. 2011. PMID: 21773661 Free article. Spanish.
Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study.
Bengió RM, Riva ME, Moiraghi B, Lanari E, Milone J, Ventriglia V, Bullorsky E, Tezanos Pinto Md, Murro H, Bianchini M, Larripa I. Bengió RM, et al. Among authors: bullorsky e. Leuk Lymphoma. 2011 Sep;52(9):1720-6. doi: 10.3109/10428194.2011.578310. Epub 2011 Jun 12. Leuk Lymphoma. 2011. PMID: 21663510
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M. Schrezenmeier H, et al. Among authors: bullorsky e. Blood. 2007 Aug 15;110(4):1397-400. doi: 10.1182/blood-2007-03-081596. Epub 2007 May 2. Blood. 2007. PMID: 17475907 Free PMC article.
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, Sillaber C, Hughes TP, Erben P, Van Tornout J, Stone RM. Apperley JF, et al. Among authors: bullorsky eo. J Clin Oncol. 2009 Jul 20;27(21):3472-9. doi: 10.1200/JCO.2007.14.3339. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487385 Free PMC article. Clinical Trial.
43 results